Biotechnology firm Transgene Biotek has received patent in the US for its novel molecule to be developed for treatment of liver cancer

Suven Life Sciences today said it has been granted a patent by Israel, Japan and South Africa for a drug used to treat neuro-degenerative d...

Biopharmaceutical firm Suven Life Sciences said it has been granted one patent each by the US, Israel and Macau for a drug used for neuroge...

The patent for 'a wearable emotion detection feedback system' was filed in October 2012, and awarded earlier this week, according to a publ...

Neuro-degenerative ailments include Alzheimer's disease, Schizophrenia and Parkinson's disease.

At 09:40 a.m.; Cipla was trading 2.4 per cent higher at Rs 742.20. It hit a low of Rs 725 and a high of Rs 744.90 in trade today.

Glenmark Pharamceuticals had filed a pre-grant opposition in September 2008 after Abott was granted a patent to Humira drug.

Suven Life Sciences surged as much as 6.97% after the co secured five product patents in Israel, Japan, China and New Zealand for NCEs.

At the NSE, it soared 19.99% to Rs 209.15. Neurodegenerative diseases include Alzheimer's disease, Schizophrenia and Parkinson's disease.

Venkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena.

DIPP has sought details from the Health Ministry regarding three medicines sold by multinationals in India to make them affordable.

Ajanta Pharma reports 75.95% increase in net profit to Rs 32.57 crore for Q3 ended December 31, 2012, mainly on robust sales.

Suven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...

India's patent authority has called for proposals to provide one-point access to databases of patent and non-patent literature of all count...

Tata Steel said it is at an advanced stage of securing partnerships for a R&D programme to produce Hydrogen from water vapors generated in ...

The government is proposing to scrap the provision for pre-grant objection to patents, as part of the forthcoming Third Amendment to the Pa...

The draft patent rules '02 published recently have found resistance from the two warring sections of the pharmaceutical industry - the Indi...